Press release
Bariatric Surgery Outperforms GLP-1 Drugs in Long-Term Weight Management and Cost Efficiency
New study underscores the sustained effectiveness and economic advantages of bariatric surgery over lifelong GLP-1 medication.BALTIMORE, MD - 16th May, 2024 - Ascension Saint Agnes Bariatric Surgery program, a leader in comprehensive obesity treatment, today announced compelling findings that bariatric surgery not only facilitates significant weight loss but also remains cost-effective compared to GLP-1 drugs in long-term obesity management.
Unlike the ongoing costs and management required with GLP-1 drugs, bariatric surgery presents a one-time investment with lasting results. Ascension Saint Agnes emphasizes a surgical approach to obesity treatment tailored to individual patient needs and health insurance considerations.
The initial cost comparison between bariatric surgery and GLP-1 drug treatments shows that, while both have similar first-year expenses, the GLP-1 therapies require ongoing costs and potential complications. In contrast, bariatric surgery, especially when part of a combined treatment plan, offers a clear financial and health advantage in the long run. This positions bariatric surgery as the superior choice for sustainable weight management.
Obesity is a complex, chronic condition necessitating multifaceted treatment strategies. "Bariatric surgery helps patients lose a substantial amount of weight quickly, decreases appetite, and provides a feeling of fullness after meals," explains a top surgeon at Ascension Saint Agnes. Moreover, the effectiveness of bariatric surgery is well-documented, with studies showing that "bariatric surgery procedures have been very successful... with the majority of the weight lost maintained off five to ten years after the procedure."
For individuals facing the challenges of morbid obesity, Ascension Saint Agnes offers a path to sustainable health improvement. With proven results and a comprehensive care model, patients can get started on their weight loss journey with confidence.
Personalized care is at the heart of Ascension Saint Agnes's approach. From initial consultations to post-surgery support, patients receive comprehensive guidance. This includes dietary advice, exercise plans, and behavioral health support, ensuring they have the tools for successful weight management.
Ascension Saint Agnes Bariatric Surgery [https://mdbariatrics.com/] program stands out with its fully credentialed status from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP). This endorsement highlights the program's commitment to quality care and patient safety.
For more information on the Ascension Saint Agnes Bariatric Surgery program and to attend a free weight-loss seminar, fill out a contact form [https://ascensionstrategycoe.formstack.com/forms/ascension_st_agnes_bariatric_surgery_center_contact_form].
Media Contact
Company Name: Ascension Saint Agnes Bariatric Surgery
Contact Person: Andrew Averbach, M.D., FACS, FASMBS
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bariatric-surgery-outperforms-glp1-drugs-in-longterm-weight-management-and-cost-efficiency]
Phone: (667) 234-8725
Address:700 Geipe Rd #274
City: Catonsville
State: MD
Country: United States
Website: https://mdbariatrics.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bariatric Surgery Outperforms GLP-1 Drugs in Long-Term Weight Management and Cost Efficiency here
News-ID: 3500115 • Views: …
More Releases from ABNewswire

Non-Cystic Fibrosis Bronchiectasis Market Expected to Gain Momentum Through 2034 …
The Key Non-Cystic Fibrosis Bronchiectasis Companies in the market include - Boehringer Ingelheim, Zambon, Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others.
DelveInsight's "Non-Cystic Fibrosis Bronchiectasis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Non-Cystic Fibrosis Bronchiectasis, historical and forecasted epidemiology as well as the Non-Cystic Fibrosis Bronchiectasis market trends in…

Victor L. Gardner Jr. Unleashes "CipherGhost," A Provocative Tech-Thriller Where …
The First Book in the Spiral Saga Explores the Battle for Memory and Truth in a Digitally Divided World, Asking How Far One Girl Must Go to Resist Erasure and Honor the Voices Silenced by a System Built on Control
A signal slips through the wires of a fractured city. A teenager listens, and nothing is the same again. Victor L. Gardner's CipherGhost is the kind of story that doesn't just…

Menkes Disease Market to Witness Promising Upswing by 2034, DelveInsight Forecas …
The Key Menkes Disease Companies in the market include - Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc., and others.
DelveInsight's "Menkes Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as the Menkes Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Menkes Disease…

Oncolytic Virus Cancer Therapy Pipeline 2025: MOA and ROA Insights, Clinical Tri …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Oncolytic Virus Cancer Therapy pipeline constitutes 120+ key companies continuously working towards developing 125+ Oncolytic Virus Cancer Therapy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Oncolytic Virus Cancer Therapy Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/oncolytic-virus-cancer-therapy-pipeline-insight-2021?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Oncolytic…
More Releases for Bariatric
Bariatric Beds Market
The Bariatric Beds Market is anticipated to witness substantial growth, driven by specialized medical beds catering to overweight individuals. Here's an overview of the market dynamics, segmentation, geographical share, and impact of COVID-19:
Market Overview:
Bariatric beds, designed for overweight individuals, offer comfort and safety, reducing bed-related health issues such as bedsores. Their wider surfaces enable enhanced mobility and ease of movement, crucial for patient recovery and overall health.
Market Dynamics:
Drivers:
Prevalence of Obesity…
Lose Weight With Bariatric Surgery
Tired of dieting hard and losing weight, just to watch the scale creep back up? Weight loss surgery is an investment in your health.
Weight loss surgery patients routinely lose 100-200 pounds and are healthier, more active, and need fewer medications than they did before weight loss surgery. Bariatric surgery is even effective at curing type II diabetes.
Bariatric surgery simply means weight loss surgery. It involves removing or sectioning off…
The Principles of Bariatric Surgery
The basic principle of bariatric surgery is to restrict food intake and decrease the absorption of food in the stomach and intestines.
Bariatric surgery may lower death rates for patients with morbid obesity, especially when coupled with healthy eating and lifestyle changes after surgery.
"Bariatric surgery is an operation that is performed in order to help individuals with extreme and excessive obesity". According to Dr. Jesus Ceja founder of Bariatric Surgery Tijuana
The…
BRIC Bariatric Surgery Devices Market Segments - Bariatric Stapling Devices, Gas …
"The Report BRIC Bariatric Surgery Devices Market Outlook to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
GlobalDatas new report, "BRIC Bariatric Surgery Devices Market Outlook to 2023", provides key market data on the BRIC Bariatric Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments -…
Australia Bariatric Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Australia Bariatric Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "Australia Bariatric Procedures Outlook to 2023", provides key procedures data on the Australia Bariatric Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and Other Methods.
The data in the report is derived from…
Russia Bariatric Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Russia Bariatric Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalData’s new report, "Russia Bariatric Procedures Outlook to 2023", provides key procedures data on the Russia Bariatric Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and Other Methods.
The data in the report is derived from…